MENU
AMPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amphastar Pharmaceuticals (AMPH) Earnings Date & Reports

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products... Show more

A.I. Advisor
published Earnings

AMPH is expected to report earnings to fall 5.30% to 88 cents per share on March 04

Amphastar Pharmaceuticals AMPH Stock Earnings Reports
Q4'25
Est.
$0.88
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.11
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.05
The last earnings report on November 06 showed earnings per share of 93 cents, beating the estimate of 82 cents. With 191.06K shares outstanding, the current market capitalization sits at 1.28B.
View a ticker or compare two or three
AMPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AMPH showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary injectable and inhalation products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
11570 6th Street
Phone
+1 909 980-9484
Employees
1761
Web
https://www.amphastar.com